中华实验外科杂志
中華實驗外科雜誌
중화실험외과잡지
CHINESE JOURNAL OF EXPERIMENTAL SURGERY
2013年
3期
530-532
,共3页
冯加锐%潘志坚%陈春洲%龙浩成%唐刚%李磊
馮加銳%潘誌堅%陳春洲%龍浩成%唐剛%李磊
풍가예%반지견%진춘주%룡호성%당강%리뢰
急性胰腺炎%血管紧张素Ⅱ%细胞间黏附分子-1%P选择素
急性胰腺炎%血管緊張素Ⅱ%細胞間黏附分子-1%P選擇素
급성이선염%혈관긴장소Ⅱ%세포간점부분자-1%P선택소
Acute pancreatitis%Angiotensin Ⅱ%Intercellular adhesion molecule-1%P-selectin
目的 探讨缬沙坦对重症急性胰腺炎(SAP)时胰腺微循环的作用及其机制.方法 假手术组(SO组)逆行胆胰管注射等量生理盐水;SAP组胆胰管逆行注射牛磺胆酸钠建立大鼠SAP模型;缬沙坦组(Ⅴ组)于造模后10 min股静脉注射缬沙坦.检测3、6、12h各组大鼠血清淀粉酶(AMY)和丙二醛(MDA)的水平及血液P选择素的表达,取胰头部胰腺组织行病理学检查,测定胰腺组织中血管紧张素Ⅱ(AngⅡ)和髓过氧化物酶(MPO)的水平,并检测胰腺组织细胞间黏附分子-1(ICAM-1)的表达.结果 Ⅴ组3、6、12h血清AMY表达水平分别为(3845.8±304.0)、(4462.6±412.9)、(4898.0±408.2) U/dl,血清MDA各时点分别为(3.64±0.82)、(3.79±0.71)、(3.94±1.03) μmol/L,胰腺组织MPO含量分别为(1.94±0.72)、(2.31 ±0.81)、(3.18±0.73) U/g,胰腺组织中AngⅡ含量分别为(124.33±15.72)、(162.42±18.81)、(220.28±19.73) ng/L,明显低于SAP组;3、6、12h血清AMY的表达水平分别为(6149.7±393.1)、(7401.4±578.5)、(9142.9±751.8) U/dl(P<0.05),MDA的表达水平分别为(4.42±1.21)、(5.61±1.17)、(5.95 ± 1.12) μmol/L(P<0.05),胰腺组织AngⅡ的含量分别为(240.90±31.46)、(273.96±27.85)、(355.72±42.77) ng/L(P<0.05),MPO的含量分别为(3.28±0.64)、(4.62±0.87)、(5.22 ±0.75) U/g(P<0.05);Ⅴ组血小板P选择素表达水平(23%)及ICAM-1的表达水平明显低于SAP组(34%,P<0.05),但都高于SO组(P<0.05).结论 SAP时胰腺组织中AngⅡ明显增加,缬沙坦对SAP有一定的保护作用;这一保护作用可能与缬沙坦抑制MDA、MPO、ICAM-1和P选择素的表达有关.
目的 探討纈沙坦對重癥急性胰腺炎(SAP)時胰腺微循環的作用及其機製.方法 假手術組(SO組)逆行膽胰管註射等量生理鹽水;SAP組膽胰管逆行註射牛磺膽痠鈉建立大鼠SAP模型;纈沙坦組(Ⅴ組)于造模後10 min股靜脈註射纈沙坦.檢測3、6、12h各組大鼠血清澱粉酶(AMY)和丙二醛(MDA)的水平及血液P選擇素的錶達,取胰頭部胰腺組織行病理學檢查,測定胰腺組織中血管緊張素Ⅱ(AngⅡ)和髓過氧化物酶(MPO)的水平,併檢測胰腺組織細胞間黏附分子-1(ICAM-1)的錶達.結果 Ⅴ組3、6、12h血清AMY錶達水平分彆為(3845.8±304.0)、(4462.6±412.9)、(4898.0±408.2) U/dl,血清MDA各時點分彆為(3.64±0.82)、(3.79±0.71)、(3.94±1.03) μmol/L,胰腺組織MPO含量分彆為(1.94±0.72)、(2.31 ±0.81)、(3.18±0.73) U/g,胰腺組織中AngⅡ含量分彆為(124.33±15.72)、(162.42±18.81)、(220.28±19.73) ng/L,明顯低于SAP組;3、6、12h血清AMY的錶達水平分彆為(6149.7±393.1)、(7401.4±578.5)、(9142.9±751.8) U/dl(P<0.05),MDA的錶達水平分彆為(4.42±1.21)、(5.61±1.17)、(5.95 ± 1.12) μmol/L(P<0.05),胰腺組織AngⅡ的含量分彆為(240.90±31.46)、(273.96±27.85)、(355.72±42.77) ng/L(P<0.05),MPO的含量分彆為(3.28±0.64)、(4.62±0.87)、(5.22 ±0.75) U/g(P<0.05);Ⅴ組血小闆P選擇素錶達水平(23%)及ICAM-1的錶達水平明顯低于SAP組(34%,P<0.05),但都高于SO組(P<0.05).結論 SAP時胰腺組織中AngⅡ明顯增加,纈沙坦對SAP有一定的保護作用;這一保護作用可能與纈沙坦抑製MDA、MPO、ICAM-1和P選擇素的錶達有關.
목적 탐토힐사탄대중증급성이선염(SAP)시이선미순배적작용급기궤제.방법 가수술조(SO조)역행담이관주사등량생리염수;SAP조담이관역행주사우광담산납건립대서SAP모형;힐사탄조(Ⅴ조)우조모후10 min고정맥주사힐사탄.검측3、6、12h각조대서혈청정분매(AMY)화병이철(MDA)적수평급혈액P선택소적표체,취이두부이선조직행병이학검사,측정이선조직중혈관긴장소Ⅱ(AngⅡ)화수과양화물매(MPO)적수평,병검측이선조직세포간점부분자-1(ICAM-1)적표체.결과 Ⅴ조3、6、12h혈청AMY표체수평분별위(3845.8±304.0)、(4462.6±412.9)、(4898.0±408.2) U/dl,혈청MDA각시점분별위(3.64±0.82)、(3.79±0.71)、(3.94±1.03) μmol/L,이선조직MPO함량분별위(1.94±0.72)、(2.31 ±0.81)、(3.18±0.73) U/g,이선조직중AngⅡ함량분별위(124.33±15.72)、(162.42±18.81)、(220.28±19.73) ng/L,명현저우SAP조;3、6、12h혈청AMY적표체수평분별위(6149.7±393.1)、(7401.4±578.5)、(9142.9±751.8) U/dl(P<0.05),MDA적표체수평분별위(4.42±1.21)、(5.61±1.17)、(5.95 ± 1.12) μmol/L(P<0.05),이선조직AngⅡ적함량분별위(240.90±31.46)、(273.96±27.85)、(355.72±42.77) ng/L(P<0.05),MPO적함량분별위(3.28±0.64)、(4.62±0.87)、(5.22 ±0.75) U/g(P<0.05);Ⅴ조혈소판P선택소표체수평(23%)급ICAM-1적표체수평명현저우SAP조(34%,P<0.05),단도고우SO조(P<0.05).결론 SAP시이선조직중AngⅡ명현증가,힐사탄대SAP유일정적보호작용;저일보호작용가능여힐사탄억제MDA、MPO、ICAM-1화P선택소적표체유관.
Objective To explore the effect of valsartan on pancreas microcirculation in rats with severe acute pancreatitis (SAP) and the action mechanism.Methods The SAP rats were randomly assigned to 3 groups:the control group (SO group),model group (SAP group) and valsartan-treated group (Ⅴ group).The rat model of SAP was established by retrograde injection of 5% sodium taurocholate into the biliopancreatic duct.SO group was subjected to bile duct retrograde injection of the same amount of physiological saline,and Ⅴ group to femoral vein injection of valsartan 10 min after modeling.The changes in serum amylase (AMY),pathology,angiotensin (Ang) Ⅱ,malondialdehyde (MDA),myeloperoxidase (MPO),intercellular adhesion molecule-1 (ICAM-1),and P-selectin in pancreatic tissues were observed.Results At 3,6 and 12 h after operation in SAP group,the contents of AMY were (6149.7 ± 393.1),(7401.4 ±578.5) and (9142.9 ± 751.8) U/dl,the contents of MDA were (4.42 ± 1.21),(5.61 ±1.17) and (5.95 ± 1.12) μmol/L,and the levels of MPO were (3.28 ±0.64),(4.62 ±0.87) and (5.22 ±0.75) U/g,the contents of AngⅡ were (240.90 ±31.46),(273.96 ±27.85) and (355.72 ±42.77) ng/L,which were significantly higher than in SO group [for AMY:(3845.8 ± 304.0),(4462.6±412.9) and (4898.0 ±408.2) U/dl; for MDA:(3.64 ±0.82),(3.79 ±0.71) and (3.94±1.03) μmol/L; for MPO:(1.94±0.72),(2.31 ±0.81) and (3.18±0.73) U/g; for AngⅡ:(124.33 ±15.72),(162.42 ± 18.81) and (220.28 ± 19.73) ng/L] (all P<0.05).The P-selectin espresssion levels (23%) and the levels of ICAM-1 in Ⅴ group were significantly lower than in SAP group (P < 0.05),but higher than in SO group (P < 0.05).The pancreatic injury in SAP group was aggravated as compared with Ⅴ group.Conclusion The Ang Ⅱ contents in the SAP rats were significantly increased in the pancreatic tissue.Valsartan had a protective effect on the pancreas of SAP rats probably by inhibiting the contents of MDA and MPO,and the expression levels of ICAM-1 and P-selectin.